CYTOSORBENTS CORPORATION

Business Segments Cytosorbents Corporation

Stocks

CTSO

US23283X3052

Advanced Medical Equipment & Technology

Market Closed - Nasdaq 16:00:00 2026-09-10 EDT			5-day change	1st Jan Change
6.370 ^USD	+0.63%		-9.00%	-50.17%

08-06	Cytosorbents Corporation, Q2 2026 Earnings Call, Aug 06, 2026
08-06	Cytosorbents Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI

Sales 2025 by Business Segment

© MarketScreener.com See more

Sales 2025 by Geography

© MarketScreener.com See more

Historical Breakdown of Revenue by Business Segments

Net Income: Breakdown by Business Segment

Geographical Revenue Distribution History

Breakdown by Business Segment (USD)

Fiscal Period: December	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Therapeutic Devices
Surgical & Medical Equipment						43.17M	34.69M	36.35M	35.59M	37.06M
Total Assets						89.52M	63.23M	53.26M	47.37M	44.18M
Interest Expense						-	-	-158K	-1.4M	-2.61M
Income Tax Expense						-736K	-1.09M	-814K	-1.69M	-401K
CAPEX						-4.28M	-6.46M	-538K	-284K	-164K
EBT						-25.29M	-33.91M	-29.32M	-22.41M	-8.6M
Gross Profit						32.12M	20.73M	22.39M	25.13M	26.49M
D&A						1.13M	1.13M	2.03M	1.74M	1.63M
Operating Income						-22.74M	-31.52M	-31.21M	-16.79M	-14.75M
Net Income						-24.56M	-32.81M	-28.51M	-20.72M	-8.2M

Geographical breakdown of sales (USD)

Fiscal Period: December	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
ALL Other Countries						17.41M	15.82M	18.05M	22.39M	25.06M
Germany						21.01M	12.57M	12.96M	13.05M	11.75M
						-	-	-	-	25.06M
United States						4.75M	6.3M	5.33M	151K	249K
						-	-	-	-	11.75M
						-	-	-	-	249K

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!

SEIZE THE OFFER!